Cargando…
Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
Autores principales: | Orange, Jordan S., Ochs, Hans D., Cunningham-Rundles, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703306/ https://www.ncbi.nlm.nih.gov/pubmed/23764872 http://dx.doi.org/10.1007/s10875-013-9912-3 |
Ejemplares similares
-
Pulmonary Embolism Secondary to Intravenous Immunoglobulin in a Child with Leukemia
por: Seren Oğuz, Işıl, et al.
Publicado: (2021) -
Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Kaarthigeyan, K., et al.
Publicado: (2011) -
Aseptic meningitis following intravenous immunoglobulin therapy of common variable immunodeficiency
por: Bhatt, Girish Chandra, et al.
Publicado: (2012) -
Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
por: Huo, Shufan, et al.
Publicado: (2022) -
Susac Syndrome With Good Response to Intravenous Immunoglobulin: A Case Report
por: Kim, Seokhyun, et al.
Publicado: (2023)